News

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
The U.S. Environmental Protection Agency has drafted a plan to eliminate all limits on greenhouse gases from coal and ...
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Rosie O'Donnell surprised fans in May 2025 by revealing a positive update on her weight loss journey — which she credited to ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...